S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
NASDAQ:VSTM

Verastem (VSTM) Price Target & Analyst Ratings

$8.13
-0.19 (-2.28%)
(As of 09/29/2023 ET)
Compare
Today's Range
$7.83
▼
$8.47
50-Day Range
$8.13
▼
$11.16
52-Week Range
$3.47
▼
$15.18
Volume
157,386 shs
Average Volume
97,265 shs
Market Capitalization
$205.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$35.14
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Verastem Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 6 Analyst Ratings

Consensus Analyst Price Target

$35.14
332.26% Upside
High Prediction$60.00
Average Prediction$35.14
Low Prediction$21.00
TypeCurrent
10/1/22 to 10/1/23		1 Month Ago
9/1/22 to 9/1/23		3 Months Ago
7/3/22 to 7/3/23		1 Year Ago
10/1/21 to 10/1/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$35.14$42.43$43.33$68.00
Predicted Upside332.26% Upside365.25% Upside420.08% Upside347.37% Upside
Get Verastem Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for VSTM and its competitors with MarketBeat's FREE daily newsletter.


VSTM Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

VSTM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Verastem Stock vs. The Competition

TypeVerastemMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.66
2.49
Consensus RatingBuyModerate BuyHold
Predicted Upside332.26% Upside869.81% Upside698.21% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/27/2023B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageBuy ➝ Buy$21.00+134.64%
8/29/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$36.00+255.38%
8/9/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOutperform ➝ Outperform$34.00 ➝ $32.00+220.00%
7/11/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$60.00 ➝ $39.00+345.21%
6/26/2023Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating		P. Stavropoulos
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target$3.00 ➝ $34.00+287.68%
5/10/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$36.00 ➝ $24.00+365.12%
10/5/2022BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy$96.00 ➝ $60.00+774.43%
(Data available from 10/1/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












VSTM Price Target - Frequently Asked Questions

What is Verastem's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Verastem stock is Buy based on the current 6 buy ratings for VSTM. The average twelve-month price prediction for Verastem is $35.14 with a high price target of $60.00 and a low price target of $21.00. Learn more on VSTM's analyst rating history.

Do Wall Street analysts like Verastem more than its competitors?

Analysts like Verastem more than other Medical companies. The consensus rating for Verastem is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how VSTM compares to other companies.

Does Verastem's stock price have much upside?

According to analysts, Verastem's stock has a predicted upside of 322.84% based on their 12-month price targets.

What analysts cover Verastem?

Verastem has been rated by B. Riley, Mizuho, Royal Bank of Canada, and Truist Financial in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:VSTM) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -